Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 210

Sort by

Sort Order Select

Journal Articles

Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment

Martin W. Schoen, MDMPH, Peter Georgantopoulos, MS, Nagasai S Yalavarthi, BS, Charles L. Bennett, MD PhD

Blood (2019) 134 (Supplement_1): 2135.

https://doi.org/10.1182/blood-2019-121770

Published: 2019

Journal Articles

Survival Benefits from Antifungal Prophylaxis and a Dedicated Inpatient Malignant Hematology Service during Induction Chemotherapy for Acute Myeloid Leukemia

Andrew Hsu, MD, Robert Matera, MD, John L. Reagan, MD, Dimitrios Farmakiotis, MD

Blood (2019) 134 (Supplement_1): 3436.

https://doi.org/10.1182/blood-2019-122264

Published: 2019

Journal Articles

Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvement of the CNS

Mark Roschewski, MD, Christopher Melani, MD, Kieron Dunleavy, MD, Matthias Holdhoff, MD PhD, Lode J. Swinnen, MB ChB, Michael Glantz, MD PhD, Craig A. Portell, MD, Jakub Svoboda, MD, Rafic Farah, MD, Michail S. Lionakis, MD ScD, Louis Staudt, MD, Wyndham Wilson, MD

Blood (2019) 134 (Supplement_1): 2875.

https://doi.org/10.1182/blood-2019-123552

Published: 2019

Journal Articles

NADPH Oxidase Controls Neutrophil Infiltration in the Lung in Early Response to Fungal Cell Walls Via LTB4

Mary C. Dinauer, MD PhD, Zhimin Song, PhD, Guangming Huang, M.S., Cliff J. Luke, PhD, Regina A. Clemens, MD PhD

Blood (2019) 134 (Supplement_1): 214.

https://doi.org/10.1182/blood-2019-130664

Published: 2019

Journal Articles

Rezafungin Prevention of Pneumocystis Pneumonia and Pneumocystis reactivation Using Different Doses and Durations of Prophylaxis in a Mouse Model

Melanie T Cushion, PhD MS, Alan Ashbaugh, Voon Ong, PhD

Blood (2019) 134 (Supplement_1): 3266.

https://doi.org/10.1182/blood-2019-127392

Published: 2019

Journal Articles

Risk-Adapted Anti-Mould Prophylaxis Improves Supportive Care in Childhood Leukemia Patients

Roman Crazzolara, MD, Julia Hutter, Josef Fritz, MD, Christina Salvador, MD, Cornelia Lass-Flörl, MD, Gabriele Kropshofer, MD

Blood (2018) 132 (Supplement 1): 3971.

https://doi.org/10.1182/blood-2018-99-110104

Published: 2018

Journal Articles

Isavuconazole in Hematological Patients: Results of a Real-Life Multicenter Seifem Study

Blood (2018) 132 (Supplement 1): 3710.

https://doi.org/10.1182/blood-2018-99-113772

Published: 2018

Journal Articles

Isavuconazole (ISAV) As Primary Anti-Fungal Prophylaxis in Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective Study

Blood (2018) 132 (Supplement 1): 2674.

https://doi.org/10.1182/blood-2018-99-111727

Published: 2018

Journal Articles

Prevalence and Clinical Characteristics of False-Positive Aspergillus Galactomannan Test in Healthy Subjects and Patients with Hematologic Malignancies

Yoshiaki Abe, Kentaro Narita, MD, Hiroki Kobayashi, MD, Akihiro Kitadate, MD PhD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2018) 132 (Supplement 1): 2408.

https://doi.org/10.1182/blood-2018-99-110939

Published: 2018

Journal Articles

Epidemiology of Visceral Mycoses in Patients with Acute Leukemia and Myelodysplastic Syndrome: Analyzing the National Autopsy Database in Japan

Tomiteru Togano, MD PhD, Yuhko Suzuki, MD PhD, William Tse, MD, Hikaru Kume, PharmD, PhD

Blood (2018) 132 (Supplement 1): 3602.

https://doi.org/10.1182/blood-2018-99-110546

Published: 2018

Journal Articles

Human Umbilical Cord Derived Mesenchymal Stromal Cells to Treat Steroid-Refractory Acute GvHD III/IV or Overlap Syndrome: Interim Analysis of a Multicenter Phase I/II Study

Maria Mico', Alessandra Algarotti, MD, Anna Grassi, MD, Chiara Pavoni, Statistician, Francesco Onida, MD, Nicola Mordini, Maria Luisa Ferrari, Federico Lussana, MD PhD, Maria Chiara Finazzi, MD, Daniela Taurino, MD, Chiara Capelli, Martino Introna, MD, Alessandro Rambaldi, MD PhD

Blood (2018) 132 (Supplement 1): 3404.

https://doi.org/10.1182/blood-2018-99-118444

Published: 2018

Journal Articles

Dose-Adjusted Teddi-R Induces Durable Complete Remissions in Relapsed and Refractory Primary CNS Lymphoma

Mark Roschewski, MD, Michail S. Lionakis, MD ScD, Christopher Melani, MD, John A. Butman, MD PhD, Stefania Pittaluga, MD PhD, A. Nicole Lucas, RN, Seth M. Steinberg, PhD, Elaine S. Jaffe, Richard F. Little, MD MPH, Louis M. Staudt, MD PhD, Wyndham H. Wilson, MD PhD

Blood (2018) 132 (Supplement 1): 4195.

https://doi.org/10.1182/blood-2018-99-112184

Published: 2018

Journal Articles

Treatment with AMG 420, an Anti-B-Cell Maturation Antigen (BCMA) Bispecific T-Cell Engager (BiTE ® ) Antibody Construct, Induces Minimal Residual Disease (MRD) Negative Complete Responses in Relapsed and/or Refractory (R/R) Multiple Myeloma (MM) Patients: Results of a First-in-Human (FIH) Phase I Dose Escalation Study

Max S. Topp, Johannes Duell, MD, Gerhard Zugmaier, Michel Attal, Philippe Moreau, Christian Langer, Jan Kroenke, MD, Thierry Facon, Hermann Einsele, Gerd Munzert, MD

Blood (2018) 132 (Supplement 1): 1010.

https://doi.org/10.1182/blood-2018-99-109769

Published: 2018

Journal Articles

Invasive Fungal Infection in the Setting of Peripheral Blood Non-Manipulated Haploidentical Stem Cell Transplantation with Postransplant Cyclophosphamide

Nieves Dorado, MD, Gillen Oarbeascoa, MD, Miguel Argüello, MD, Pascual Balsalobre, PhD, David Serrano, MD, Carolina Martínez-Laperche, Rebeca Bailén, MD, Javier Anguita, MD PhD, Jose Luis Díez-Martín, MD PhD, Mi Kwon

Blood (2018) 132 (Supplement 1): 5710.

https://doi.org/10.1182/blood-2018-99-118765

Published: 2018

Journal Articles

Risk of Invasive Fungal Infections in Patients with High-Risk MDS and AML Receiving Hypomethylating Agents

Gee Youn (Geeny) Kim, PharmD, Jonathan Burns, PharmD, Craig W. Freyer, PharmD, Keith Hamilton, MD, Mindy Schuster, MD MSCE, Noelle V. Frey, MD, Elizabeth O. Hexner, MD MS, James K. Mangan, MD PhD, Mary Ellen Martin, MD, Shannon R. McCurdy, MD, Alexander E. Perl, MD, David L. Porter, MD, Selina Luger, MD, Alison W. Loren, MD MS

Blood (2018) 132 (Supplement 1): 5512.

https://doi.org/10.1182/blood-2018-99-119168

Published: 2018

Journal Articles

Incidence of Breakthrough Invasive Fungal Infections after Posaconazole Prophylaxis in Allogeneic Stem Cell Transplant Patients

Rayaz Ahmed, MD DM, Sanghmitra Thakur, MSc, Jyotsna Kapoor, MSc, Narendra Agrawal, MD DM, Pallavi Mehta, MD DM, Shinto Francis Thekuddan, MD DM, Ambar Garg, MD, Dinesh Bhurani, MD DM, FRCPA

Blood (2018) 132 (Supplement 1): 5695.

https://doi.org/10.1182/blood-2018-99-118157

Published: 2018

Journal Articles

Real-World Efficacy of Anti-Fungal Prophylaxis in Patients Treated for Acute Gastrointestinal Graft- Versus- host Disease (GI-GVHD)

Yin Yuan, Ashleigh P Scott, MBBS FRACP FRCPA

Blood (2018) 132 (Supplement 1): 5697.

https://doi.org/10.1182/blood-2018-99-112332

Published: 2018

Journal Articles

Pharmacokinetic-Pharmacodynamic Analyses to Provide Rezafungin Prophylaxis Dose Selection for Prevention of Invasive Fungal Infections for Bone Marrow Transplant Patients

Elizabeth A Lakota, PharmD, MS, Shawn Flanagan, PhD, Taylor Sandison, MD, MPH, Janice W Brown, MD, Christopher M Rubino, Pharm.D.

Blood (2018) 132 (Supplement 1): 2071.

https://doi.org/10.1182/blood-2018-99-110300

Published: 2018

Journal Articles

Allergic Sensitization Is Associated with Decreased Risk of ED Visits and Hospitalizations for Pain in Sickle Cell Disease

Christy Sadreameli, MD, M.H.S., Benjamin Kopp, MD, M.P.H., Susan E Creary, MD, Emily Jacobs, B.S., John J Strouse, MD PhD, Sharon A. McGrath-Morrow, MD, James F. Casella, MD, Elizabeth C. Matsui

Blood (2018) 132 (Supplement 1): 3676.

https://doi.org/10.1182/blood-2018-99-119743

Published: 2018

Journal Articles

CD11b Regulates Fungal Outgrowth but Not Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

Daniel Teschner, MD, Anna Cholaszczyńska, Frederic Ries, Hendrik Beckert, Matthias Theobald, Stephan Grabbe, MD, Markus P. Radsak, MD, Matthias Bros, PhD

Blood (2018) 132 (Supplement 1): 3690.

https://doi.org/10.1182/blood-2018-99-111843

Published: 2018

NARROW

Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment

Survival Benefits from Antifungal Prophylaxis and a Dedicated Inpatient Malignant Hematology Service during Induction Chemotherapy for Acute Myeloid Leukemia

Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvement of the CNS

NADPH Oxidase Controls Neutrophil Infiltration in the Lung in Early Response to Fungal Cell Walls Via LTB4

Rezafungin Prevention of Pneumocystis Pneumonia and Pneumocystis reactivation Using Different Doses and Durations of Prophylaxis in a Mouse Model

Risk-Adapted Anti-Mould Prophylaxis Improves Supportive Care in Childhood Leukemia Patients

Isavuconazole in Hematological Patients: Results of a Real-Life Multicenter Seifem Study

Isavuconazole (ISAV) As Primary Anti-Fungal Prophylaxis in Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective Study

Prevalence and Clinical Characteristics of False-Positive Aspergillus Galactomannan Test in Healthy Subjects and Patients with Hematologic Malignancies

Epidemiology of Visceral Mycoses in Patients with Acute Leukemia and Myelodysplastic Syndrome: Analyzing the National Autopsy Database in Japan

Human Umbilical Cord Derived Mesenchymal Stromal Cells to Treat Steroid-Refractory Acute GvHD III/IV or Overlap Syndrome: Interim Analysis of a Multicenter Phase I/II Study

Dose-Adjusted Teddi-R Induces Durable Complete Remissions in Relapsed and Refractory Primary CNS Lymphoma

Invasive Fungal Infection in the Setting of Peripheral Blood Non-Manipulated Haploidentical Stem Cell Transplantation with Postransplant Cyclophosphamide

Risk of Invasive Fungal Infections in Patients with High-Risk MDS and AML Receiving Hypomethylating Agents

Incidence of Breakthrough Invasive Fungal Infections after Posaconazole Prophylaxis in Allogeneic Stem Cell Transplant Patients

Real-World Efficacy of Anti-Fungal Prophylaxis in Patients Treated for Acute Gastrointestinal Graft- Versus- host Disease (GI-GVHD)

Pharmacokinetic-Pharmacodynamic Analyses to Provide Rezafungin Prophylaxis Dose Selection for Prevention of Invasive Fungal Infections for Bone Marrow Transplant Patients

Allergic Sensitization Is Associated with Decreased Risk of ED Visits and Hospitalizations for Pain in Sickle Cell Disease

CD11b Regulates Fungal Outgrowth but Not Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only